All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe

Article

Equipment and Processing Report

May 18, 2011

Equipment and Processing Report

Equipment and Processing Report-05-18-2011
Volume0
Issue 0

May 2011 Editor's Picks: Products from David Round Company and Globe Medical Tech

Author(s):

Pharmaceutical Technology Editors

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the May 2011 edition from David Round Company and Globe Medical Tech.

David Round Company
Lift tables incorporate protected hydraulic packages

The David Round Company’s 304 stainless-steel lift tables are designed for bulk-material applications in controlled pharmaceutical manufacturing environments (e.g., cleanrooms). The machines’ hydraulic packages are laid out flat on the bottom of the tables, and the cylinders are in a horizontal position. This design enables the hydraulic components to be covered, thus protecting them and reducing opportunities for contamination.

Personnel can operate the tables’ hydraulic packages with pushbutton controls. The tables can be raised from 18 in. to as high as 42 in., which is within the appropriate ergonomic range. The tables’ reinforced scissors-type lift capacity is rated at 2000 lb.

The tables are mounted on wheels for portability, and personnel can collapse them to the floor. In addition, the tables’ highly polished finish, smooth welds, and few crevices enable easy wash down.

Globe Medical Tech
Prefilled syringes enhance safety

Globe Medical Tech’s dual- and single-chamber prefilled syringes are designed to enhance safety. The syringes’ integrated needle-stick prevention feature and vacuum needle autoretraction technology provide full compliance with US and European safety regulations. After injection, the needle is retracted into the syringe body with a gentle push on the plunger. The syringe does not need any activation (e.g., twisting or capping) to engage the safety and contains no springs or metal components.

In combination with material and lubricant selections, the single- and dual-chamber syringes help maximize pharmaceutical compatibility. The dual-chamber syringe maintains the pharmaceutical components in separate chambers, thus extending the shelf life of some drugs. The syringes are made with medical-grade plastics that comply with FDA and international pharmacopoeial regulations. The plastics are compatible with a wide range of pharmaceutical drugs, and the components offer biocompatibility and low leachability. The syringes are designed to reduce dosing errors and contamination.

Articles in this issue

Do Particulate-Inspection Methods Need Scrutiny?
Finding the Right Balance
GMT-syringeWEB-722543-1408621958425.jpg
May 2011 Editor's Picks: Products from David Round Company and Globe Medical Tech
Manual and Automated Filling of Powder in Capsules for Clinical Trials

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave A Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, CSO, AustinPx
Related Content
Advertisement
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 15th 2025

FDA Commissioner Applauds Florida Restriction on 7-OH Opioids

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 15th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 15th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 15th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Stem cells - undifferentiated (immature) cells on the background of a DNA helix, 3d rendering | Image Credit: © ustas - stock.adobe.com
August 15th 2025

Optimizing Testing in Cell and Gene Therapy: A Key Driver for Industry Growth and Adoption

Ambili Menon
Pendulum used for readings and hypnotism swinging with motion blur | Image Credit: © fergregory - stock.adobe.com
August 15th 2025

Prasad Returns to Head FDA’s CBER

Christopher Cole
Related Content
Advertisement
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 15th 2025

FDA Commissioner Applauds Florida Restriction on 7-OH Opioids

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 15th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 15th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 15th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Stem cells - undifferentiated (immature) cells on the background of a DNA helix, 3d rendering | Image Credit: © ustas - stock.adobe.com
August 15th 2025

Optimizing Testing in Cell and Gene Therapy: A Key Driver for Industry Growth and Adoption

Ambili Menon
Pendulum used for readings and hypnotism swinging with motion blur | Image Credit: © fergregory - stock.adobe.com
August 15th 2025

Prasad Returns to Head FDA’s CBER

Christopher Cole
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.